Low-Molecular-Weight Heparin (LMWH) in Women with Repeated Implantation Failure

Low-Molecular-Weight Heparin (LMWH) in Women with Repeated Implantation Failure.

Despite the initial dramatic improvements in success rates and significant increments in uptake of assisted reproduction techniques (ARTs), the live birth rate resulting from these techniques has recently plateaued [1]. Greater emphasis is now being placed on experimental strategies to further improve oocyte and embryo number and quality, implantation rates, and successful transition to live bi...

Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.

Thromboembolic complications are a common and costly medical problem, associated with significant morbidity and mortality, especially in postoperative patients. There have been reports of death due to thromboembolic complications even after short procedures, e.g. arthroscopy. Low-molecular-weight heparins (LMWHs) (e.g., certoparin, dalteparin, enoxaparin, nadroparin, reviparin, tinzaparin) have...

Cytokine Profile in the Endometrium of Normal Fertile and Women with Repeated Implantation Failure

Background: Repeated Implantation Failure (RIF) is one of the most intricate obstacles in assisted reproduction. The cytokine and chemokine composition of uterine cavity seem to play important roles in the implantation process. Objective: To compare the cytokine profile in the endometrium of normal fertile women and those with repeated implantation failure. Methods: After enzymatic digestion of...

Low Molecular Weight Heparin Overdose: A 10 Year Case Series

  Background: Low molecular weight heparin (LMWH) is used for the treatment and prevention of coagulative disorders. Few patients receiving therapeutic doses of LMWH develop major hemorrhage. Currently there are few reports in the literature on acute overdose on adults.  In this study, clinical profile, treatment and outcome of 21 patients who acutely overdosed enoxaparin are described. Method...

Low molecular weight heparin.